INTRODUCTION
sion times, due to the small fraction of mononuclear cells conforming to the hMSC phenotype. To improve the efficiency of hMSC expansion alternative sources, Discovery of stem cell populations that exhibit proclivity to differentiate into specialized tissue types has such as adipose tissue, novel methods of culture are under investigation (10,27). provided the foundation for regenerative medicine (40) . A case in point are human mesenchymal stem cells Initially, culture of hMSCs was established with fetal bovine serum (FBS), an adjuvant routinely used in cell (hMSCs) that exhibit multipotency with a capacity for differentiation into cardiac, adipose, chondrocyte, or os-culture (48) . Although the overall risk of zoonoses associated with FBS culture is thought to be small, a call for teoblast lineages, and offer a patient-derived renewable source to support tissue restoration (7, 23, 38, 39) . With greater scrutiny in stem cell banks for prions and zoonotic pathogens has been issued (14, 16 ). Furthermore, low levels of human leukocyte antigen, this immunoprivileged adult cytotype modulates rather than provokes recent reports have raised concern for the potential of immunogenic reaction at the time of transplantation due immune response in the allogeneic state, distinguishing hMSC as favored candidates for tissue reconstitution to xenogenic proteins transmitted from FBS to hMSCs during culture (47) . Specific cases have documented the (1, 31) . Experience to date has largely relied on bone marrow as the source for hMSC derivation (BM-hMSC) risk for anaphylactoid response after implantation of cells cultured in FBS, with reported diffuse urticaria and (24, 29, 53) . As bone marrow is a heterogeneous tissue, composed of several stem cell pools, use of this resource production of antibodies against FBS proteins after repeated stem cell treatment cycles (20, 24, 45, 47) . In ad-necessitates large explants or protracted ex vivo expan-798 CRESPO-DIAZ ET AL. dition, the culture environment has been noted to differ-about 5 min, and incubated in 0.075% collagenase type I (Worthington Biochemical, Lakewood, NJ) for 90 min entially regulate cell cycle transcripts of hMSC proliferation and influence lineage differentiation when compared at 37°C. Digested tissue was centrifuged at 400 × g for 5 min with the pellet washed in PBS, passed through a to that of stem cells cultured with humanized culture adjuvants (19) . The lot-to-lot variability seen with FBS 70-µm cell strainer (BD Biosciences, San Jose, CA), and incubated in red blood cell lysis buffer (154 mmol/L creates an inherent heterogeneity in the derivation and propagation of hMSCs. As such, the use of FBS impedes NH 4 Cl, 10 mmol/L KHCO 3 , 0.1 mmol/L EDTA). Expansion media consisted of DMEM with 10% fetal adherence to regulatory requirements, hampering development of clinically applicable cell-based products (8, 33) .
bovine serum or advanced MEM with 5% platelet lysate, 100 U/ml penicillin, 100 g/ml streptomycin, and 2 mM To overcome potential hurdles associated with FBSbased culture, testing of nonzoonotic substitutes is war-L-glutamine (Invitrogen, Carlsbad, CA). Cell yield was quantified with a hemocytometer. ranted (8, 33, 41, 46) . Such substitutes should mimic naturally occurring microenvironments to optimally support GMP-Adherent Platelet Lysate Procurement hMSC proliferation while maintaining cell phenotype, multipotency, and chromosomal stability. In this regard, Standard blood donor criteria as determined by the Mayo Clinic Blood Bank were utilized for platelet har-platelets provide a unique opportunity for stem cell culture as they consist of intracellular granules abundant in vest and lysate procurement. There was no selection bias, as all outdated platelets from 500 distinct donors potent reparative and mitogenic substances (35). At the time of tissue injury, these bioactive factors are released were lysed and pooled into 50 lots containing between 8 and 12 donors (15). Laminar-flow cabinet sterility and into a resultant clot and exert extensive influence on tissue regeneration by triggering stromal cell proliferation, air quality were maintained at International Organization for Standardization (ISO) 5 within an environment con-migration, and differentiation. Moreover, hMSC proliferation and chemotaxis in tissue homeostasis and resto-forming to ISO 7 standards. Routine environmental monitoring was implemented for adherence to microbial, ration are a direct response to signals following injury (55). Ex vivo recapitulation of this nurturing paradigm airborne particle, air pressure differential, temperature, and humidity standards. The manufacture using a freeze-would allow, in principle, the formulation of a milieu capable of supporting expansion of hMSCs for clinical thaw approach, composition, and release of platelet lysate was subject to quality assurance (maintenance of translation.
Compared to standard FBS, good manufacturing hMSC phenotype, viral and bacterial sterility, and product stability with full traceability of all material utilized) and practice (GMP)-adherent pooled human platelet lysate (GMP-hPL) provided here an adjuvant for accelerated independent oversight [certifying both environmental quality and validated standard operating procedures (SOP) expansion, maintenance of phenotype stability, and absence of clonal chromosomal aberrancy in BM-hMSC for hPL manufacture]. Each generated batch fulfilled tracking criteria imposed by GMP standards, including and adipose tissue hMSC (AT-hMSC) cultures. Proteomic dissection of this nonzoonotic milieu resolved sig-quarantine during batch testing and release with demonstration of verified quality and purity characteristics (15). nals that clustered within nonstochastic pathways of tissue repair and cell proliferation, identifying the molecular Flow Cytometry of hMSCs substrate underlying human platelet lysate support of efficient and safe hMSC procurement.
Isolated cells were collected and immunostained for analysis of cell surface expression using an Aria SE flow MATERIALS AND METHODS cytometer and Cell Quest Pro software (BD Biosci-Isolation and Culture of hMSCs From Bone Marrow ences). Cells were incubated with either CD34-fluoresand Adipose Tissue cein isothiocyanate (FITC), CD14, CD44, CD45, CD73, HLA-DR, and HLA-ABC (all from BD Biosciences), All patient-derived tissues were obtained in full compliance and approval of local institutional review boards along with CD105, CD90 (eBioscience, San Diego, CA) and CD133 (Cell Signaling Technologies) (37). (IRB). Bone marrow aspirates were obtained from iliac crest or sternum of 12 patients, washed with PBS, and Proliferation Assay centrifuged at 400 × g for 5 min. The pellet was treated with red blood cell lysis buffer for 5 min at 4°C, centri-Bone marrow-and adipose tissue-derived hMSCs were initially plated at 5,000 cells/cm 2 in 10% FBS or fuged, resuspended, and cultured in expansion media. Human adipose tissue was obtained under IRB guide-5% GMP-hPL supplemented media (equivalent to platelet-derived media supplement; Mill Creek Life Sciences, lines from different anatomic compartments in 20 patients undergoing liposuction, appendectomy, bariatric, Rochester, MN) and passaged for a total of five passages representing a total of 40-60 cell division events de-or hernia operations, minced with surgical scalpels for pending on the condition. Cumulative population dou-(QFQ-banding), followed by G-banding using trypsin and Leishman's stain. Karyotyping was performed using bling (CPD) was calculated using the formula: [log 10 (N H ) − log 10 (N 1 )]/log 10 2, where N H is the harvested cell the Applied Imaging CytoVision Karyotyping System. Spectral karyotyping analysis (SKY) was performed on number and N 1 is the plated cell number (8). Each passage was calculated and added to the population dou-metaphase chromosomal preparations subjected to single hybridization with fluorochrome-labeled DNA libraries bling of the previous passage to obtain the CPD. The generation time (i.e., the time between two cell dou-specific for each of the 24 chromosomes. Results were visualized with a SpectraCube, Sagnac interferometer. blings) was calculated as: [log 10 2 × ∆t]/[log 10 (N H ) − log 10 (N 1 )], where ∆t is the time between passages (8).
SKY images correlated with conventional chromosome banding results and were confirmed with chromosome-Lineage Differentiation specific painting prior to interpretation. Osteogenic and adipogenic differentiation was achieved with a Mesenchymal Stem Cell Osteogenic Stimulatory Proteomics Kit and the Mesenchymal Stem Cell Adipogenic Stimu-Dissection of platelet lysate composition was achieved latory Supplements (Stem Cell Technologies), respecusing a human-specific label-based ELISA array (Raytively. Chondrogenic differentiation was achieved by ag-Biotech). Here, 100 µl of platelet lysate was dialyzed gregating cells at a density of 2 × 10 4 cells/µl of for 9 h in 500 ml of pH 8.0 PBS, with PBS exchanged induction medium DMEM high glucose, 4.5 g/L (Inat every 3-h interval, biotin-labeled, and dialyzed for an vitrogen), 100 U/ml penicillin, 100 µg/ml streptomycin, additional 9-12 h in pH 8.0 PBS. Array incubation with 4 mM L-glutamine, 1 mM sodium pyruvate, 0.17 mM dialyzed biotin-labeled platelet lysate was performed by ascorbic acid 2-phosphate, 0.1 µM dexamethasone, 1× overnight incubation at 4°C followed by hybridization ITS supplement, 0.35 mM L-proline (all from Sigmawith GFP-labeled biotin-targeted secondary antibody. Aldrich). Cell aggregates were then plated as droplets of Proteomic array results were compiled and quantified 20 µl in a six-well culture dish and allowed to adhere for using a GenePix 4000B fluorescence scanner and soft-2 h, followed by addition of 2 ml of induction medium.
ware. Quantified data were manually organized to corre-Aggregates were cultured for 3 weeks, before differentispond to Swiss-Prot, Genbank, and OMIM identification ation was assessed. Cardiogenic differentiation was for entry into the Ingeniuty and GeneGo network analyachieved by subjecting cultured hMSC in a 5% platelet sis software suites (2,56). Protein expression was relysate condition with a cocktail of recombinant growth stricted to display data demonstrating values 10-fold factors as previously described for a 5-day period (5, 6) .
greater than that of background in all three array repli-Following cocktail stimulation, cardiac progenitor cells cates. were placed in a 1% platelet lysate milieu to achieve terminal myocardial differentiation (7, 22) .
Network Analysis Using Ingenuity Pathways Analysis and the Meta-Histology and Immunostaining
Core database, molecular interactions within the platelet Prior to antibody incubation, cells were fixed in 3% lysate were examined to generate scoring and prioritizaparaformaldehyde and permeablized with 0.1% Triton Xtion of networks/pathways according to the relevance 100. The following antibodies were used for staining to within the initial list of root objects (17). Significance address cell plasticity: Oct-4 (1:100, R&D Systems), was based on overlap between imported datasets and ca-SOX-2 (1:200, Cell Signaling Technologies), CD133, and nonical pathways as evaluated with hypergeometric dis-CD90-FITC. Cardiac commitment was evaluated with:
tribution. The mean of this distribution was calculated Mef2C (1:400, Cell Signaling Technologies), Nkx2.5 (1: as µ = Σ[n,r = 0]rP(r,n,R,N) = (nR/N) = nq; where N 150, Santa Cruz Biotechnology Inc.), Gata-4 (1:150, Santa equals total number of MetaCore database nodes, R Cruz Biotechnology Inc.), sarcomeric protein α-actinin (1: equals number of network objects corresponding to ana-500, Sigma-Aldrich), and human-specific cardiac tropolyzed genes and proteins, n equals total number of nodes nin-I (1:100, Abcam) (5) . Histologic processing with Oil in each small network generated from imported dataset, red-O was performed to assess for adipogenesis, Safraninr equals number of nodes with data in each small net-O (Sigma-Aldrich) for chondrogenesis, and Alizarin Red work generated from imported dataset, and q is the ratio for osteogenesis. Images were obtained with LSM 510/ of R/N. Dispersion was calculated σ 2 = r 2 P(r,n,R,N) − LSM 700 laser scanning confocal or Apotome structured
((n − 1)/(N − 1)). Internetwork prioritization based on Chromosomal Analysis imported datasets was measured by z-score = (r − µ)/σ, ranking subnetworks according to saturation with root Twenty metaphases cells from 20 distinct patient hMSC cultures underwent Q-banding using quinacrine objects. Finally, confidence interval evaluation of net-work relevance to Gene Ontology biologic processes cells depleted of the surface markers CD45, CD14, and CD34 and expressing CD133, previously reported to be a was measured as
marker for freshly harvested multipotent MSC, lost upon adherence to plastic ( Fig. 1D ) (3, 50) . The population ex-R − n + i)!)). Network interconnectivity analysis corresponding to established wound healing and cell prolifera-
1% of the total mononuclear cell fraction derived from tion signaling ontologies was probed to determine overrepresentation of subnetwork clusters. Both physical and adipose tissue, comparable to that observed in bone marrow. Adipose tissue derived hMSCs in FBS demonstrated functional interactions were represented within network objects. Network interconnectivity represented as (k) was a fivefold increase in growth ( Fig. 2A ) and enhanced cumulative population doubling ( Fig. 2B ) over BM-hMSCs plotted against the probability of achieving nonstochastic interaction (P(k)) to engender cluster coefficient plots.
(n = 6 patients for each group assessed over 5 passages). The 5% platelet lysate condition, efficient in cultivation Identified over-or underrepresented nodes were probed versus canonical repair and proliferation pathways to de-of BM-hMSCs, was evaluated with adipose tissue-derived hMSCs (AT-hMSCs) to validate its broader utility. AT-termine significance through coordinate adherence in a Cartesian plot format (17).
hMSCs from six patients were cultured either in 10% FBS or 5% GMP-hPL demonstrating, over a 5-passage obser-Statistics vation period, maintenance of platelet lysate proliferation Data are presented as mean ± SD representing a 95% advantage (Fig. 2C ). This improvement translated into a confidence interval (JMP 8; SAS Institute). Paired group decrease in generation times from 3.6 ± 0.5 in FBS to analysis was performed using Student's t-test, and nonpar-1.7 ± 0.4 days in GMP-hPL at early passage (<10 populaametically validated using Wilcoxon signed rank test. A tion doublings) and 2.9 ± 0.4 in FBS to 2.0 ± 0.2 days in value of p < 0.05 was considered significant. Multiple GMP-hPL at late passage (>30 population doublings) comparison studies were validated by means of Bonfer- (Fig. 2D ). Thus, GMP-hPL demonstrated a strong mitoroni and Tukey's methods (JMP 8).
genic influence on hMSCs to support their ex vivo cultivation, regardless of tissue of origin and throughout the RESULTS culture period.
Nonzoonotic Culture Enhances hMSC Growth Profile
Nonzoonotic Condition Maintains Phenotype Stability Expired apheresis platelets from multiple donors were pooled into single lots to provide a nonzoonotic, GMP-Preservation of mesenchymal stem cell phenotype following protracted culture (12 passages) revealed a surface hPL culture condition. Culture of BM-hMSC obtained from 6 individual patients was made in standard FBS at receptor profile devoid of CD14, CD34, CD45, and HLA-DR (class II) with positive expression of CD44, CD90, 10%, and compared to culture in GMP-hPL at 1%, 2.5%, or 5% (Fig. 1A, B ). BM-hMSC cultured in the 5% GMP-CD105, and HLA-ABC (class I) demonstrated >70 population doublings in six patient-derived hMSCs in either hPL condition demonstrated significant increase in proliferation capacity versus lower GMP-hPL concentrations FBS or GMP-hPL conditions. This profile was noted to be stable throughout the culture period for FBS (Fig. 3A) , and FBS (Fig. 1A ) over a 5 passage observation period. Generation time in early passages (P1-3) was quantified and highly enriched in the GMP-hPL condition (Fig. 3B ). Immunocytochemistry markers of stemness, such as Oct-as 2.5 ± 0.5, 2.9 ± 0.6, 9.2, and 7.7 ± 2.5 days for 5% GMP-hPL, 2.5% GMP-hPL, 1% GMP-hPL, and FBS, re-4 and Sox2 previously shown to be expressed in a variety of somatic and stromal stem cells (26, 28, 50) , were found spectively (Fig. 1B) . In late passage (P5), generation times were quantified as 2.5 ± 0.4, 3.0 ± 0.6, 7.3, 5.0 ± 1.0 days to colocalize in CD133-or CD90-expressing cells, respectively, in both the GMP-hPL and FBS culture conditions for 5% GMP-hPL, 2.5% GMP-hPL, 1% GMP-hPL, and FBS, respectively (Fig. 1B) .
(26) (Fig. 3C ).. GMP-hPL lot-to-lot variability was assessed in 50 distinct lots, identifying only limited variabil-To generalize the GMP-hPL based approach, adipose tissue hMSC was derived from different anatomic com-ity in population doubling times (0.8 ± 0.2) ( Fig. 3D ). Furthermore, cells passaged in 50 different hPL lots re-partments and was obtained either in homogenized form from specimens after liposuction or in tissue bloc after vealed limited phenotype variability with robust maintenance of hallmark hMSC surface markers demonstrating surgical excision (Table 1) . Equivalent volumes of freshly homogenized adipose tissue and bone marrow were evalu-on average 95 ± 5% expression for CD44, CD73, CD90, and CD105, as well as 85 ± 8% expression of HLA-ABC, ated for total mononuclear cell yield. Adipose tissue provided a 10-fold greater quantity of cells per volume in and no expression of HLA-DR or 1 ± 1% expression of CD14 and CD45 (Fig. 3E) . Moreover, late passage stem comparison to bone marrow (Fig. 1C ). Enrichment of hMSC population was achieved by FACS analysis for cells cultured in the GMP-hPL condition demonstrated To address the impact of ex vivo expansion on risk for cell transformation, chromosomal stability of hMSCs and Alizarin Red (Fig. 4A-C) . Lineage commitment to the cardiac program (22) , termed cardiopoiesis (5), was was evaluated after long-term culture in GMP-hPL or FBS condition. At passage 12, 20 distinct patient-utillized on naive hMSCs (day 0) to induce nuclear translocation of early (Nkx2.5) and late (MEF2C) cardiac tran-derived hMSCs were analyzed for 20 metaphases when grown in serum-free GMP-hPL condition with no clonal scription factors (day 5) (7) (Fig. 4D) . Immature organization of cardiac sarcomeric proteins, α-actinin and karyotypic derangements noted on traditional chromosomal smearing (Fig. 5A) . In contrast, two of the pa-troponin-I, was detected 15 days after induction of cardiopoiesis but fully mature myocytes were not obtained in tient-derived hMSCs evaluated at passage 12 in the FBS condition demonstrated cell transformation with clonal the 2D ex vivo culture conditions. Therefore, culture in GMP-hPL was devoid of lot-to-lot variability with ro-chromosomal aberrations including t(1:15) translocation for one patient (45 years old) and gain of a chromosome bust cellular proliferation, and maintenance of phenotype stability or multipotency.
+21 with loss of −X for another patient (51 years old) The subnetwork topology conformed to a high degree tracellular signaling proteins expressed within GMP-hPL, as identified through proteomic and network analysis, were probed for 11 different GMP-hPL lots with ELISA analysis demonstrating conserved expression of ( Fig. 5B ). Of note, no chromosomal aberrations were noted in the same patients in nonzoonotic GMP-hPL TGF-β (125 ± 15 ng/ml), IGF-1 (130 ± 25 ng/ml), EGF (20 ± 3 ng/ml), PDGF (10 ± 3 ng/ml), VEGF (450 ± 130 culture ( Fig. 5A and B are from the same two patients). High sensitivity spectral karyotyping (SKY) verified the pg/ml), and FGF (195 ± 100 pg/ml) ( Fig. 7E) . Thus, proteomic dissection of the platelet lysate here identified stability of hMSCs grown in the nonzoonotic platelet lysate condition, as no clonal chromosomal aberrancies pathways central to healing as the molecular basis for the in vitro mitogenic effect and stability imposed on beyond normal and typical background changes were noted (Fig. 5C ). Thus, hMSCs grown in the zoonotic hMSCs. FBS condition carry an apparent risk for transformation, DISCUSSION a phenomenon not observed in hMSCs grown in serumfree GMP-hPL condition for extended periods of culture This study identifies adipose tissue as an alternative body compartment to bone marrow for higher hMSC typical of production for clinical application.
yield. Compared to FBS, this work further demonstrates Proteomic Dissection of GMP-hPL Reveals human platelet lysate as a superior adjuvant to expedite Repair-Associated Signaling Cascades derivation and proliferation of hMSCs regardless of source, while protecting against chromosomal aberrancy To decode extracellular influence exerted by platelet lysate during expansion of hMSCs, GMP-hPL was sub-over protracted culture periods. Proteomic dissection of this nonzoonotic milieu identifies highly ranked signal-jected to high-throughput proteomic array analysis. Datasets were performed in triplicate and filtered based on ing pathways, delineating the molecular basis for human platelet lysate-mediated mitogenic and stabilizing influ-background levels. Positive identification of proteins was made if expression exceeded negative controls by ence on the hMSC phenotype.
To date, expansion of hMSCs in FDA-approved clin->10-fold in all three samples achieving a value of p < 0.001. Signaling pathways intrinsic to wound healing ical trials has been typically in the presence of FBS (24, 25, 29, 32, 49, 51, 53) . The association of this standard were uncovered via integration of GMP-hPL-expressed cytokines and growth factors into a network using unbi-practice with risk of virus and prion transfer along with zoonotic protein internalization and carryover has now ased bioinformatics algorithms (Fig. 6A) . Additionally, nonarbitrary network evaluation with Ingenuity and been reported (13,14,46,47) . In addition, the potential for deleterious outcome following cellular transplanta-ties for clinical trials revealed transient and donor-dependent recurring aneuploidy (48) . Indeed, under zoonotic tion due to xenogenic protein-triggered immunogenicity or arrhythmogenesis has also been documented (11,16, culture conditions, mesenchymal stem cells have been reported to undergo spontaneous clonal transformation 47). Here, a donor-derived nonzoonotic platelet lysate, produced under good manufacturing practice (GMP) at early or late passages with loss of phenotype and abnormal metabolism (18, 42, 43) . In our hands, FBS cell guidelines, was utilized to act as a substitute for FBS in the derivation and culture of clinical grade hMSCs.
culture for periods mimicking ex vivo expansion of clinical trials may carry a potential for clonal genomic insta-hMSCs cultured in this milieu demonstrated a growth profile exceeding that of FBS while preserving cell phe-bility, complicating therapeutic interventions. Such clonal chromosomal aberrancy was here not observed in hMSCs notype and multipotency when derived from either bone marrow or adipose tissue. The use of platelet lysate pro-cultured in the platelet lysate condition with either standard or highly sensitive SKY karyotyping analysis, en-vided a humanized serum replacement adjuvant that conformed to all GMP guidelines to be utilized in the suring safety in cell transplantation. The platelet lysate environment was conducive to an derivation and stable expansion of hMSCs for clinical applications.
increase in cell proliferation. The rationale behind this cellular response to platelet lysate is thought to originate Furthermore, despite evidence for genomic instability associated with the use of FBS, it has been argued that from mitogenic signals enriched within the clot that are released as platelets degranulate during tissue repair the risk for neoplastic change does not occur with passage numbers typical of clinical trials (42). However, (35). Solid phase combinatorial ligand libraries have been utilized to capture and detect proteins of low abun-recent evaluation of cells produced in cell therapy facili- Table 1 ) organized into a nonstochastic network. (B) Rank ordered evaluation of biologic processes using two distinct nonarbitrary network evaluation software programs (Ingenuity-orange, GeneGo-red, both-green) independently identified wound repair and associated mechanisms as a priori biological processes. dance, and deplete high-abundance proteins such as al-factors have been shown to have mitogenic action in the healing wound as their direct application achieves tissue bumin (9). Here the label-based approach, implemented for high-throughput proteomic analysis, provided a plat-repair (52) . The EGF receptor (EGFR) is dramatically upregulated after injury, and has been postulated to pro-form to dissect the proteome of the platelet lysate, uncovering distinct canonical pathways collectively con-vide functional redundancy in the signaling paradigm of repair (21). The TGF-β superfamily has a broad spec-forming to the repair paradigm. Of the identified pathways, PDGF has been suggested as a major player trum of function with key roles in tissue differentiation homeostasis and repair (5, 34, 54) . The CCL (e.g., mono-in wound healing (52) , and is the first growth factor to be approved for use in the treatment of nonhealing ul-cyte chemoattractant proteins) family of chemokines has a well-established proinflammatory function during cers (36) . This pathway along with VEGF receptor signaling has been recently shown critical in cell recruit-wound repair with chemoattractant activity on bone marrow cells (12,52), and capacity to induce cell prolifera-ment to sites of neovascularization in vivo (4). Members of the FGF family have broad impact on cytoprotection tion. Indeed, a role for these signaling effectors on stem cell proliferation has been noted (4, 30, 38, 44) . Network and survival under stress conditions. Furthermore, these 
